BIOMAT Database Logo BIOMAT Database Logo

High-dose intravenous gammaglobulin in Guillain-Barré syndrome. 1988

F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
[Guillain-Barré syndrome: response to high dose intravenous gammaglobulin therapy in a 12-year old girl].
August 1991, Anales espanoles de pediatria,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
[Effect of high-dose gammaglobulin on a case of Guillain-Barré syndrome].
May 1993, No to hattatsu = Brain and development,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin.
November 1992, The New Zealand medical journal,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barré syndrome.
November 1991, Lancet (London, England),
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome.
March 1992, Anaesthesia,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome.
October 1995, Italian journal of neurological sciences,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
Single high-dose intravenous immunoglobulin for treatment of pediatric Guillain-Barré syndrome.
March 1998, Journal of child neurology,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
[High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].
December 2007, Klinische Monatsblatter fur Augenheilkunde,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
High-dose steroid therapy in Guillain-Barré syndrome.
December 1988, Journal of neuroimmunology,
F G van der Meché, and R P Kleyweg, and J Meulstee, and P G Oomes
High-dose intravenous gammaglobulin.
April 1985, Lancet (London, England),
Copied contents to your clipboard!